The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
| VWINX | |
| Total Expense Ratio | 0.23 |
| Annual Report Gross Expense Ratio | 0.23 |
| Fund Existence | 55 years |
| Gain YTD | 10.726 |
| Front Load | N/A |
| Min. Initial Investment | 3000 |
| Min. Initial Investment IRA | N/A |
| Net Assets | 49.3B |
| Annual Yield % from dividends | 3.35 |
| Returns for 1 year | 5.45 |
| Returns for 3 years | 10.17 |
| Returns for 5 years | 3.18 |
| Returns for 10 years | 29.66 |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBB | 170.28 | 1.35 | +0.80% |
| iShares Biotechnology ETF | |||
| IPO | 48.39 | 0.13 | +0.27% |
| Renaissance IPO ETF | |||
| EYLD | 39.01 | 0.09 | +0.23% |
| Cambria Emerging Shareholder Yield ETF | |||
| AMOM | 49.56 | -0.10 | -0.20% |
| QRAFT AI-Enhanced US Large Cap Mmntm ETF | |||
| PLTG | 34.86 | -0.12 | -0.34% |
| Leverage Shares 2X Long PLTR Daily ETF | |||